{
  "report_rows": [
    {
      "kpi": "Fiscal Q4 2026 adjusted EPS",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.68 vs. cons $1.67",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Fiscal Q4 2026 net sales",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.91B vs. cons $1.913B",
      "confidence": "HIGH"
    },
    {
      "kpi": "Fiscal Q4 2026 gross margin",
      "prediction": "IN-LINE",
      "answer": "pred ~41.7% vs. cons 41.5%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "LOWER",
      "answer": "guide ~$5.65 vs. cons $6.00 (FY2027)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Net sales",
      "prediction": "LOWER",
      "answer": "guide ~$7.42B vs. cons $7.57B (FY2027)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic sales growth",
      "prediction": "LOWER",
      "answer": "guide ~1.0% vs. cons 3.0% (FY2027)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -6.5,
  "day1_confidence": "HIGH",
  "day5_residual_pct": -8.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FY2027 adjusted-EPS guidance of ~$5.65 versus ~$6.00 consensus implies roughly 6% estimate cuts; weak organic-growth and margin assumptions should outweigh an approximately in-line Q4 and drive continued downward revisions.",
  "day5_confidence": "MEDIUM"
}